Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
1.703
-0.397 (-18.91%)
Nov 16, 2026, 3:30 PM EST - Market open
Aligos Therapeutics Revenue
Aligos Therapeutics had revenue of $2.87M in the quarter ending September 30, 2026, with 287.18% growth. This brings the company's total for the last twelve months to $33.65M, up 1,171.58% year-over-year. In the year 2025, Aligos Therapeutics had annual revenue of $2.19M, down -44.59%. That makes Aligos Therapeutics the 30,665th largest company in the world by revenue and 4,043rd in the United States.
Revenue (ttm)
$33.65M
Revenue Growth
+1,171.58%
P/S Ratio
0.31
Revenue / Employee
$410,317
Employees
82
Market Cap
10.64M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.19M | -1.76M | -44.59% |
| Dec 31, 2024 | 3.95M | -11.58M | -74.60% |
| Dec 31, 2023 | 15.53M | 1.62M | 11.66% |
| Dec 31, 2022 | 13.91M | 9.55M | 219.04% |
| Dec 31, 2021 | 4.36M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bolt Biotherapeutics | 4.70M |
| Kyntra Bio | 4.62M |
| Seres Therapeutics | 2.13M |
| Pluri | 1.46M |
| Daré Bioscience | 1.37M |
| Neuphoria Therapeutics | 1.17M |
| BioCardia | 3.00K |
| Fractyl Health | 3.00K |
ALGS News
- 10 days ago - Aligos Therapeutics reports Q3 EPS ($2.09), consensus ($2.53) - TheFly
- 10 days ago - Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results - GlobeNewsWire
- 10 days ago - Aligos Therapeutics Earnings release: Q3 2026 - Filings
- 10 days ago - Aligos Therapeutics Quarterly report: Q3 2026 - Filings
- 10 days ago - Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2026 - GlobeNewsWire
- 6 weeks ago - Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026 - GlobeNewsWire
- 2 months ago - Aligos Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 2 months ago - Aligos Therapeutics to Present at the Cantor Global Healthcare Conference - GlobeNewsWire